SCHEMBL1786229

SCHEMBL1786229

CCCc1c(C=O)c(-c2ccccc2)c(C(C)=O)n1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
ALDH1A1 P00352 3/20 0.34
LMNA P02545 1/20 0.34
KDM4E B2RXH2 4/20 0.33
GRIA2 P42262 1/20 0.33
GRIA4 P48058 1/20 0.33
GAA P10253 1/20 0.33
PTGES O14684 1/20 0.33
TSHR P16473 1/20 0.33
RCE1 Q9Y256 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
MAPT P10636 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
POLB P06746 1/20 0.32
THRB P10828 1/20 0.32
HPGD P15428 1/20 0.31
CASP1 P29466 1/20 0.31
CSF1R P07333 1/20 0.31
FGFR1 P11362 1/20 0.31
FLT1 P17948 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1785116 0.91 PTGES (0.38) CYP1A2ALDH1A1KDM4EPTGESSMN1; SMN2
SCHEMBL1785884 0.76
SCHEMBL12607004 0.75
SCHEMBL1782719 0.66 HTT (0.49) CYP1A2ALDH1A1LMNAGRIA2GRIA4
SCHEMBL12650842 0.65 SMN1; SMN2 (0.43) CYP1A2ALDH1A1LMNAKDM4EGAA
SCHEMBL1788002 0.63 HSD17B10 (0.33) ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL12651072 0.63 LMNA (0.31) ALDH1A1LMNAKDM4EGAA
SCHEMBL1666507 0.62 MAPT (0.36) ALDH1A1LMNAMAPT
SCHEMBL12607030 0.61 IMPDH2 (0.30)
SCHEMBL12679971 0.61 LMNA (0.50) ALDH1A1LMNAMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273901-B2 Process of forming a pyrrole compound Nanyang Technical University (SG) 2012-09-25 US disclosed
US-8273901-B2 Process of forming a pyrrole compound Nanyang Technical University (SG) 2012-09-25 US disclosed
US-8273901-B2 Process of forming a pyrrole compound Nanyang Technical University (SG) 2012-09-25 US disclosed
US-20110124881-A1 PROCESS OF FORMING A PYRROLE COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2011-05-26 US disclosed
US-20110124881-A1 PROCESS OF FORMING A PYRROLE COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2011-05-26 US disclosed
US-20110124881-A1 PROCESS OF FORMING A PYRROLE COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124881-A1 PROCESS OF FORMING A PYRROLE COMPOUND OXER1, OGDH, OPRD1 CYP1A2 60/4885ALDH1A1 67/4885LMNA 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.